1. Home
  2. Labeler Index
  3. Emergent Biosolutions Canada Inc.
  4. 60492-0173
  5. NDC Package Code: 60492-0173-2 Cnj-016

NDC Package 60492-0173-2 Cnj-016

Vaccinia Immune Globulin (human) Injection Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
60492-0173-2
Package Description:
24 VIAL, SINGLE-USE in 1 CARTON / 12 mL in 1 VIAL, SINGLE-USE (60492-0173-1)
Product Code:
60492-0173
Proprietary Name:
Cnj-016
Non-Proprietary Name:
Vaccinia Immune Globulin (human)
Substance Name:
Human Vaccinia Virus Immune Globulin
Usage Information:
CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) is indicated for the treatment and/or modification of the following conditions:•Eczema vaccinatum•Progressive vaccinia•Severe generalized vaccinia•Vaccinia infections in individuals who have skin conditions such as burns, impetigo, varicella-zoster, or poison ivy; or in individuals who have eczematous skin lesions because of either the activity or extensiveness of such lesions•Aberrant infections induced by vaccinia virus that include its accidental implantation in eyes (except in cases of isolated keratitis), mouth, or other areas where vaccinia infection would constitute a special hazard.Exercise caution when using VIGIV in the treatment of patients having complication due to vaccinia vaccination that include concomitant vaccinia keratitis, since a single study in rabbits has demonstrated increased corneal scarring upon intramuscular vaccinia immune globulin administration in vaccinia keratitis (1).VIGIV is not considered to be effective in the treatment of postvaccinial encephalitis.
11-Digit NDC Billing Format:
60492017302
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1922329 - Human vaccinia immune globulin 50,000 UNT in 20 ML Injection
  • RxCUI: 1922329 - 20 ML human vaccinia immune globulin 2500 UNT/ML Injection
  • RxCUI: 1922329 - Human vaccinia immune globulin 50,000 UNT per 20 ML Injection
  • RxCUI: 1922334 - CNJ-016 50,000 UNT in 20 ML Injection
  • RxCUI: 1922334 - 20 ML human vaccinia immune globulin 2500 UNT/ML Injection [CNJ-016]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Emergent Biosolutions Canada Inc.
    Dosage Form:
    Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Active Ingredient(s):
  • HUMAN VACCINIA VIRUS IMMUNE GLOBULIN 1 [iU]/mL
    • Pharmacologic Class(es):
  • Human Immunoglobulin G - [EPC] (Established Pharmacologic Class)
  • Immunoglobulins - [CS]
  • Passively Acquired Immunity - [PE] (Physiologic Effect)
  • Virus Neutralization - [MoA] (Mechanism of Action)
  • Virus-specific Hyperimmune Globulins - [EXT]
    • Sample Package:
    No
    FDA Application Number:
    BLA125109
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    05-01-2005
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 60492-0173-2?

    The NDC Packaged Code 60492-0173-2 is assigned to a package of 24 vial, single-use in 1 carton / 12 ml in 1 vial, single-use (60492-0173-1) of Cnj-016, a human prescription drug labeled by Emergent Biosolutions Canada Inc.. The product's dosage form is injection and is administered via intravenous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 60492-0173 included in the NDC Directory?

    Yes, Cnj-016 with product code 60492-0173 is active and included in the NDC Directory. The product was first marketed by Emergent Biosolutions Canada Inc. on May 01, 2005 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 60492-0173-2?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 60492-0173-2?

    The 11-digit format is 60492017302. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-160492-0173-25-4-260492-0173-02